Chasing Cancer

The consequences of the novel coronavirus were a huge challenge for people living with cancer - from delayed screenings that led to advanced disease to concerns about being exposed to the virus during critical treatments. As we get back to in-person care, Washington Post Live will bring together leading oncologists, researchers and patients to discuss the impact of the novel coronavirus on cancer, lessons learned and how the vaccine has not protected some immunocompromised patients as hoped. We'll look at whether the technology harnessed during the pandemic - from artificial intelligence to gene editing to CAR T-cell therapy has the potential to transform cancer care. Join the conversation on Wednesday, July 28.